143 related articles for article (PubMed ID: 38297181)
1. The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID.
Matsumoto C
Hypertens Res; 2024 Apr; 47(4):984-986. PubMed ID: 38297181
[No Abstract] [Full Text] [Related]
2. Covid-19: US studies show racial and ethnic disparities in long covid.
Tanne JH
BMJ; 2023 Mar; 380():535. PubMed ID: 36878599
[No Abstract] [Full Text] [Related]
3. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of long COVID-19.
Jacobs MM; Evans E; Ellis C
J Natl Med Assoc; 2023 Apr; 115(2):233-243. PubMed ID: 36792456
[TBL] [Abstract][Full Text] [Related]
4. FDA approved L-type channel blocker Nifedipine reduces cell death in hypoxic A549 cells through modulation of mitochondrial calcium and superoxide generation.
Manohar K; Gupta RK; Gupta P; Saha D; Gare S; Sarkar R; Misra A; Giri L
Free Radic Biol Med; 2021 Dec; 177():189-200. PubMed ID: 34666149
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
[TBL] [Abstract][Full Text] [Related]
6. Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis.
Alsagaff MY; Mulia EPB; Maghfirah I; Luke K; Nugraha D; Rachmi DA; Septianda I; A'yun MQ
Diabetes Metab Syndr; 2021; 15(5):102210. PubMed ID: 34298269
[TBL] [Abstract][Full Text] [Related]
7. An intersectional analysis of long COVID prevalence.
Cohen J; van der Meulen Rodgers Y
Int J Equity Health; 2023 Dec; 22(1):261. PubMed ID: 38093291
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020.
Van Dyke ME; Mendoza MCB; Li W; Parker EM; Belay B; Davis EM; Quint JJ; Penman-Aguilar A; Clarke KEN
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(11):382-388. PubMed ID: 33735165
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
[TBL] [Abstract][Full Text] [Related]
10. Acute calcium channel blocker withdrawal-induced cardiac arrest.
Peeters LEJ; den Uil CA; Feyz L; van den Bemt PMLA; Daemen J; Versmissen J
Neth J Med; 2019 Dec; 77(9):341-343. PubMed ID: 31814590
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
Choksi TT; Zhang H; Chen T; Malhotra N
Am J Nephrol; 2021; 52(3):250-260. PubMed ID: 33827074
[TBL] [Abstract][Full Text] [Related]
12. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
13. Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years - Long Beach, California, April 1-December 10, 2020.
Yomogida K; Zhu S; Rubino F; Figueroa W; Balanji N; Holman E
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(37):1274-1277. PubMed ID: 34529639
[TBL] [Abstract][Full Text] [Related]
14. Omicron variants of SARS-CoV-2 and long COVID.
Yang C; Zhao H; Shannon CP; Tebbutt SJ
Front Immunol; 2022; 13():1061686. PubMed ID: 36569883
[TBL] [Abstract][Full Text] [Related]
15. Trends in Calcium Channel Blocker Use in Patients with Heart Failure with Reduced Ejection Fraction and Comorbid Atrial Fibrillation.
Cholack G; Garfein J; Krallman R; Montgomery D; Kline-Rogers E; Rubenfire M; Bumpus S; Md TC; Barnes GD
Am J Med; 2021 Nov; 134(11):1413-1418.e1. PubMed ID: 34245675
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of use of beta blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home.
Aronow WS
J Am Geriatr Soc; 1996 Sep; 44(9):1075-7. PubMed ID: 8790234
[TBL] [Abstract][Full Text] [Related]
17. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
Haddad H; Searles G; Gillis A
Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
[TBL] [Abstract][Full Text] [Related]
18. Inequity and disparities mar existing global research evidence on Long COVID.
Taghrir MH; Akbarialiabad H; Abdollahi A; Ghahramani N; Bastani B; Paydar S; Razani B; Mwangi J; Asadi-Pooya AA; Roozbeh J; Malekmakan L; Kumar M
Glob Health Promot; 2023 Mar; 30(1):63-67. PubMed ID: 35962520
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020.
Shiels MS; Haque AT; Haozous EA; Albert PS; Almeida JS; García-Closas M; Nápoles AM; Pérez-Stable EJ; Freedman ND; Berrington de González A
Ann Intern Med; 2021 Dec; 174(12):1693-1699. PubMed ID: 34606321
[TBL] [Abstract][Full Text] [Related]
20. Association of Antihypertensive Agents with the Risk of In-Hospital Death in Patients with Covid-19.
Chouchana L; Beeker N; Garcelon N; Rance B; Paris N; Salamanca E; Polard E; Burgun A; Treluyer JM; Neuraz A;
Cardiovasc Drugs Ther; 2022 Jun; 36(3):483-488. PubMed ID: 33595761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
